Literature DB >> 14993107

The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation.

Samuel N Heyman1, Zohair Hanna, Taher Nassar, Ahuva Shina, Sa'ed Akkawi, Marina Goldfarb, Seymour Rosen, Abd-Al Roof Higazi.   

Abstract

1. The renal medulla is a major source of plasminogen activators (PA), recently shown to induce vasodilation in vitro. Treatment with PA inhibitors has been associated with renal dysfunction, suggesting compromised renal microvasculature. We investigated the impact of the PA inhibitor epsilon amino-caproic acid (EACA) upon vascular tone in vitro, and studied the effect of both tPA and EACA upon intrarenal hemodynamics in vivo. 2. In vitro experiments were carried out in isolated aortic rings and with cultured vascular smooth muscle cells. Studies of renal microcirculation and morphology were conducted in anesthetized Sprague-Dawley rats. 3. In isolated aortic rings, EACA (but not the other inhibitors of the fibrinolytic system PAI-1 or alpha-2 antiplasmin) reduced the half-maximal effective concentration of phenylephrine (PE) required to induce contraction (from 32 nm in control solution to 2 and 0.1 nm at EACA concentrations of 1 and 10 microm, respectively). Using reteplase (retavase) in the same model, we also provide evidence that the vasoactivity of tPA is in part kringle-dependent. In cultured vascular smooth muscle cells, Ca(2+) internalization following PE was enhanced by EACA, and retarded by tPA. 4. In anesthetized rats, EACA (150 mg x kg(-1)) did not affect systemic blood pressure, total renal or cortical blood flow. However, the outer medullary blood flow declined 12+/-2% below the baseline (P<0.03). By contrast, tPA (2 mg x kg(-1)), transiently increased outer medullary blood flow by 8+/-5% (P<0.02). Fibrin microthrombi were not found within the renal microvasculature in EACA-treated animals. 5. In conclusion, both fibrinolytic and antifibrinolytic agents modulate medullary renal blood flow with reciprocal effects of vasodilation (PA) and vasoconstriction (EACA). In vitro studies suggest that these hemodynamic responses are related to direct modulation of the vascular tone.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14993107      PMCID: PMC1574281          DOI: 10.1038/sj.bjp.0705714

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  Renal microthrombosis. Incidence in 500 consecutive autopsies. Clinico-pathological relations.

Authors:  O Myhre-Jensen; E S Hansen; B Butrago
Journal:  Acta Pathol Microbiol Scand A       Date:  1972

2.  Consumption coagulopathy and acute renal failure due to gram-negative septicemia after abortion. Complete recovery with heparin therapy.

Authors:  A R Clarkson; R E Sage; J R Lawrence
Journal:  Ann Intern Med       Date:  1969-06       Impact factor: 25.391

3.  Cardiac and renal hemodynamic effects of the antifibrinolytic agent, epsilon aminocaproic acid.

Authors:  C Swartz; G Onesti; O Ramirez; N Shah; A N Brest
Journal:  Curr Ther Res Clin Exp       Date:  1966-07

4.  Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy.

Authors:  C Charytan; D Purtilo
Journal:  N Engl J Med       Date:  1969-05-15       Impact factor: 91.245

5.  Vasodilation, fibrinolysis, and thrombolysis with intraarterial infusion of urokinase in the canine superior mesenteric artery.

Authors:  N Gurll; M J Zinner; L Turtinen; D G Reynolds
Journal:  Gastroenterology       Date:  1978-09       Impact factor: 22.682

6.  Thrombotic thrombocytopenic purpura with acute anuric renal failure.

Authors:  G Dunea; R C Muehrcke; S Nakamoto; F D Schwartz
Journal:  Am J Med       Date:  1966-12       Impact factor: 4.965

7.  The association of epsilon-aminocaproic acid with postoperative decrease in creatinine clearance in 1502 coronary bypass patients.

Authors:  M Stafford-Smith; B Phillips-Bute; D N Reddan; J Black; M F Newman
Journal:  Anesth Analg       Date:  2000-11       Impact factor: 5.108

8.  In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone.

Authors:  Taher Nassar; Sa'ed Akkawi; Ahuva Shina; Abdullah Haj-Yehia; Khalil Bdeir; Mark Tarshis; Samuel N Heyman; Abd Al-Roof Higazi
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

9.  Binding of urokinase to low density lipoprotein-related receptor (LRP) regulates vascular smooth muscle cell contraction.

Authors:  Taher Nassar; Abdullah Haj-Yehia; Sa'ed Akkawi; Alice Kuo; Khalil Bdeir; Andrew Mazar; Douglas B Cines; Abd Al-Roof Higazi
Journal:  J Biol Chem       Date:  2002-08-08       Impact factor: 5.157

10.  Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report.

Authors:  R R Tubbs; S P Benjamin; D E Dohn
Journal:  J Neurosurg       Date:  1979-07       Impact factor: 5.115

View more
  5 in total

1.  Plasminogen activator inhibitor-1 regulates myoendothelial junction formation.

Authors:  Katherine R Heberlein; Adam C Straub; Angela K Best; Mark A Greyson; Robin C Looft-Wilson; Poonam R Sharma; Akshaya Meher; Norbert Leitinger; Brant E Isakson
Journal:  Circ Res       Date:  2010-02-04       Impact factor: 17.367

Review 2.  Effect of drug interventions on cerebral hemodynamics in ischemic stroke patients.

Authors:  Osian Llwyd; Jui-Lin Fan; Martin Müller
Journal:  J Cereb Blood Flow Metab       Date:  2021-11-05       Impact factor: 6.200

3.  Therapeutic targeting of extracellular DNA improves the outcome of intestinal ischemic reperfusion injury in neonatal rats.

Authors:  Michael Boettcher; Georg Eschenburg; Stefan Mietzsch; Miguel Jiménez-Alcázar; Michaela Klinke; Deirdre Vincent; Bastian Tiemann; Robert Bergholz; Konrad Reinshagen; Tobias A Fuchs
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

4.  A high value of fibrinogen in immunoglobulin A nephropathy patients is associated with a worse renal tubular atrophy/interstitial fibrosis score.

Authors:  Mengyun Tu; Sipin Hu; Zhengqing Lou
Journal:  J Clin Lab Anal       Date:  2021-11-16       Impact factor: 2.352

Review 5.  The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis.

Authors:  Yosuke Kanno
Journal:  Int J Mol Sci       Date:  2019-01-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.